ApicHope Pharmaceutical Co., Ltd. (300723) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

ApicHope Pharmaceutical Co., Ltd.

Why is ApicHope Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -12.52% and Operating profit at -210.75% over the last 5 years

With ROE of 11.51%, it has a very expensive valuation with a 7.58 Price to Book Value

Over the past year, while the stock has generated a return of -29.44%, its profits have risen by 137% ; the PEG ratio of the company is 0.5
At the current price, the company has a high dividend yield of 0

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 21.43% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -29.44% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is ApicHope Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

ApicHope Pharmaceutical Co., Ltd.

-32.42%

0.87

70.57%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-12.52%

EBIT Growth (5y)

-210.75%

EBIT to Interest (avg)

7.32

Debt to EBITDA (avg)

1.10

Net Debt to Equity (avg)

0.87

Sales to Capital Employed (avg)

0.42

Tax Ratio

12.64%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.68%

ROE (avg)

9.84%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.58

EV to EBIT

-47.67

EV to EBITDA

-101.63

EV to Capital Employed

5.87

EV to Sales

16.32

PEG Ratio

0.48

Dividend Yield

ROCE (Latest)

-12.31%

ROE (Latest)

11.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 518.57 MM

ROCE(HY)

Highest at 10.33%

RAW MATERIAL COST(Y)

Fallen by -23.02% (YoY

NET SALES(Q)

Highest at CNY 385.47 MM

PRE-TAX PROFIT(Q)

Highest at CNY 592.69 MM

NET PROFIT(Q)

Highest at CNY 594.38 MM

EPS(Q)

Highest at CNY 1.33

-21What is not working for the Company

NET SALES(HY)

At CNY 503.74 MM has Grown at -14.24%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.23 times

INTEREST(Q)

At CNY 15.89 MM has Grown at 12.54%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.95 times

Here's what is working for ApicHope Pharmaceutical Co., Ltd.

Pre-Tax Profit

At CNY 592.69 MM has Grown at 885.78%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 594.38 MM has Grown at 950.35%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 518.57 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 385.47 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 592.69 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 594.38 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 1.33

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -23.02% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for ApicHope Pharmaceutical Co., Ltd.

Interest

At CNY 15.89 MM has Grown at 12.54%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio

Lowest at 2.23 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Inventory Turnover Ratio

Lowest at 1.95 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio